These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 12592387)

  • 1. CHD5, a new member of the chromodomain gene family, is preferentially expressed in the nervous system.
    Thompson PM; Gotoh T; Kok M; White PS; Brodeur GM
    Oncogene; 2003 Feb; 22(7):1002-11. PubMed ID: 12592387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of novel human neuronal leucine-rich repeat (hNLRR) family genes and inverse association of expression of Nbla10449/hNLRR-1 and Nbla10677/hNLRR-3 with the prognosis of primary neuroblastomas.
    Hamano S; Ohira M; Isogai E; Nakada K; Nakagawara A
    Int J Oncol; 2004 Jun; 24(6):1457-66. PubMed ID: 15138588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tumour suppressor CHD5 forms a NuRD-type chromatin remodelling complex.
    Kolla V; Naraparaju K; Zhuang T; Higashi M; Kolla S; Blobel GA; Brodeur GM
    Biochem J; 2015 Jun; 468(2):345-52. PubMed ID: 25825869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Definition and characterization of a region of 1p36.3 consistently deleted in neuroblastoma.
    White PS; Thompson PM; Gotoh T; Okawa ER; Igarashi J; Kok M; Winter C; Gregory SG; Hogarty MD; Maris JM; Brodeur GM
    Oncogene; 2005 Apr; 24(16):2684-94. PubMed ID: 15829979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The gene for a new brain specific RhoA exchange factor maps to the highly unstable chromosomal region 1p36.2-1p36.3.
    De Toledo M; Coulon V; Schmidt S; Fort P; Blangy A
    Oncogene; 2001 Nov; 20(50):7307-17. PubMed ID: 11704860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of CHD5 Inactivation in neuroblastomas.
    Koyama H; Zhuang T; Light JE; Kolla V; Higashi M; McGrady PW; London WB; Brodeur GM
    Clin Cancer Res; 2012 Mar; 18(6):1588-97. PubMed ID: 22294723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three chromosomal rearrangements in neuroblastoma cluster within a 300-kb region on 1p36.1.
    Spieker N; Beitsma M; Van Sluis P; Chan A; Caron H; Versteeg R
    Genes Chromosomes Cancer; 2001 Jun; 31(2):172-81. PubMed ID: 11319804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CHD5, a tumor suppressor gene deleted from 1p36.31 in neuroblastomas.
    Fujita T; Igarashi J; Okawa ER; Gotoh T; Manne J; Kolla V; Kim J; Zhao H; Pawel BR; London WB; Maris JM; White PS; Brodeur GM
    J Natl Cancer Inst; 2008 Jul; 100(13):940-9. PubMed ID: 18577749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and sequence analysis of candidates for the 1p36.31 tumor suppressor gene deleted in neuroblastomas.
    Okawa ER; Gotoh T; Manne J; Igarashi J; Fujita T; Silverman KA; Xhao H; Mosse YP; White PS; Brodeur GM
    Oncogene; 2008 Jan; 27(6):803-10. PubMed ID: 17667943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms.
    Martinsson T; Sjöberg RM; Hedborg F; Kogner P
    Cancer Res; 1995 Dec; 55(23):5681-6. PubMed ID: 7585654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of CHD5 in human cancers: 10 years later.
    Kolla V; Zhuang T; Higashi M; Naraparaju K; Brodeur GM
    Cancer Res; 2014 Feb; 74(3):652-8. PubMed ID: 24419087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma.
    Kong XT; Choi SH; Inoue A; Xu F; Chen T; Takita J; Yokota J; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Hayashi Y
    Cancer Res; 1997 Sep; 57(17):3772-8. PubMed ID: 9288786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of novel genes located at the t(1;15)(p36.2;q24) translocation breakpoint in the neuroblastoma cell line NGP.
    Amler LC; Bauer A; Corvi R; Dihlmann S; Praml C; Cavenee WK; Schwab M; Hampton GM
    Genomics; 2000 Mar; 64(2):195-202. PubMed ID: 10729226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An integrated 5-Mb physical, genetic, and radiation hybrid map of a 1p36.1 region implicated in neuroblastoma pathogenesis.
    Spieker N; Beitsma M; van Sluis P; Roobeek I; den Dunnen JT; Speleman F; Caron H; Versteeg R
    Genes Chromosomes Cancer; 2000 Feb; 27(2):143-52. PubMed ID: 10612802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological characteristics of neuroblastoma with partial deletion in the short arm of chromosome 1.
    Hiyama E; Hiyama K; Ohtsu K; Yamaoka H; Fukuba I; Matsuura Y; Yokoyama T
    Med Pediatr Oncol; 2001 Jan; 36(1):67-74. PubMed ID: 11464909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. cDNA cloning, molecular characterization, and chromosomal localization of NET(EPHT2), a human EPH-related receptor protein-tyrosine kinase gene preferentially expressed in brain.
    Tang XX; Biegel JA; Nycum LM; Yoshioka A; Brodeur GM; Pleasure DE; Ikegaki N
    Genomics; 1995 Sep; 29(2):426-37. PubMed ID: 8666391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of genomic imprinting at 1p35-36 in neuroblastoma.
    Hogarty MD; Maris JM; White PS; Guo C; Brodeur GM
    Med Pediatr Oncol; 2001 Jan; 36(1):52-5. PubMed ID: 11464906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of pleiotrophin and midkine in advanced neuroblastomas.
    Nakagawara A; Milbrandt J; Muramatsu T; Deuel TF; Zhao H; Cnaan A; Brodeur GM
    Cancer Res; 1995 Apr; 55(8):1792-7. PubMed ID: 7712489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMGI(Y) and HMGI-C genes are expressed in neuroblastoma cell lines and tumors and affect retinoic acid responsiveness.
    Giannini G; Di Marcotullio L; Ristori E; Zani M; Crescenzi M; Scarpa S; Piaggio G; Vacca A; Peverali FA; Diana F; Screpanti I; Frati L; Gulino A
    Cancer Res; 1999 May; 59(10):2484-92. PubMed ID: 10344762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chromatin remodeling factor CHD5 is a transcriptional repressor of WEE1.
    Quan J; Adelmant G; Marto JA; Look AT; Yusufzai T
    PLoS One; 2014; 9(9):e108066. PubMed ID: 25247294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.